BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8191435)

  • 1. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):341-5. PubMed ID: 8191435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical mass screening in Norway--510,000 smears a year.
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Cancer Detect Prev; 1994; 18(6):463-70. PubMed ID: 7867019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
    Magnus K; Langmark F
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1557-9. PubMed ID: 2187277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening programme in Primorsko-Goranska County, Croatia--the results of the pilot study.
    Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Janković S; Glibotić-Kresina H; Brncić-Fischer A; Benić-Salamon K
    Coll Antropol; 2010 Mar; 34(1):225-32. PubMed ID: 20437641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
    Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Campaign for cervical cancer screening with vaginal smears in women aged 50-69 years in Isère (France). Results of the first round (January 1991-June 1993)].
    Garnier A; Exbrayat C; Bolla M; Marron J; Winckel P; Billette de Villemeur A
    Bull Cancer; 1997 Aug; 84(8):791-5. PubMed ID: 9339183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fitzroy Valley Pap Smear Register. Cervical screening in a population of Australian aboriginal women.
    Mak DB; Straton JA
    Med J Aust; 1993 Feb; 158(3):163-6. PubMed ID: 8450781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass screening for cervical cancer in Norway: evaluation of the pilot project.
    Bjørge T; Gunbjørud AB; Haugen OA; Skare GB; Tropé C; Thoresen SO
    Cancer Causes Control; 1995 Nov; 6(6):477-84. PubMed ID: 8580294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry.
    Pettersson F; Näslund I; Malker B
    IARC Sci Publ; 1986; (76):91-105. PubMed ID: 3570419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.